Health ❯ Healthcare ❯ Clinical Research

Drug Efficacy

Clinical Trials Weight Loss Medications Side Effects Weight Loss Studies Pharmacokinetics Patient Outcomes Treatment Outcomes Beta-Blockers in Cardiac Patients Ivermectin and Cancer Weight Regain

Ivermectin Combo Prescriptions Jump After Mel Gibson Podcast, Study Finds

Experts say viral claims can quickly shift care toward unproven drugs.

FOI Reveals Two Suspected GLP‑1 Drug Deaths in Northern Ireland

Liraglutide Patent Expiry Triggers Cheaper Weight‑Loss Generics in Germany

Argentina Launches Lilly’s Mounjaro for Obesity and Diabetes After ANMAT Approval

FDA Opens Safety Review of Infant RSV Antibody Drugs Beyfortus and Enflonsia

Real-World Study Finds Semaglutide and Tirzepatide Cut Cardiovascular Risk in Type 2 Diabetes

Major Meta-Analysis Finds No Post–Heart Attack Benefit From Beta-Blockers When Heart Function Is Preserved

The Lancet Review Finds Antidepressants Differ Sharply in Weight, Heart Rate and Blood Pressure Effects

Major Review Finds Tramadol Delivers Minimal Chronic Pain Relief and Higher Serious Harm Risk

EU Approves Donanemab as Second Alzheimer’s Antibody Under Tight Conditions

Trials Recast Post–Heart Attack Beta-Blocker Use, With Signal of Harm in Women

Wegovy Becomes First GLP-1 Therapy Approved by FDA for MASH

EU Approves First Alzheimer's Drug Targeting Disease Progression

EU Commission Approves First Alzheimer’s Therapy Targeting Disease Progression

EMA Approves Lecanemab for Early-Stage Alzheimer’s Treatment in EU

Eli Lilly's Zepbound Shows Promise in Reducing Heart Failure Risks